A new clinical trial with selective digestive decontamination;Un nuevo ensayo clínico con descontaminación digestiva selectiva

Medicina Intensiva

Volumn 33, Issue 6, 2009, Pages 297-300

  García Hierro, Paloma ^a   de la Cal, Miguel A ^a   van Saene, Hendrick K F ^b   Silvestri, Luciano ^c  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Presidio Ospedaliero ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; POLYMYXIN; QUINOLONE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CANDIDA; CANDIDIASIS; CLINICAL TRIAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL CONTAMINATION; MORTALITY; PNEUMONIA; PREVALENCE; STAPHYLOCOCCAL BACTEREMIA;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL ILLNESS; DECONTAMINATION; HUMANS; OROPHARYNX; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349280344     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/S0210-5691(09)72198-9     Document Type: Article

References (20)

1. De Smet A.M., Kluytmans J.A., Cooper B.S., Mascini E.M., Benus R.F., Van der Werf T.S., et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360 (2009) 20-31
2. Taylor N., Van Saene H.K.F., Abella A., Silverstri L., Vucic M., and Peric M. Descontaminación digestiva selectiva. ¿Por qué no aplicamos la evidencia en la práctica clínica?. Med Intensiva 31 (2007) 136-145
3. Liberati A., D'Amico R., Pifferi, Torri V., and Brazzi L. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev (2004) CD000022
4. Campbell M.K., Elbourne D.R., and Altman D.G. CONSORT statement: extension to cluster randomised trials. BMJ 328 (2004) 702-708
5. Kerry S.M., and Bland J.M. Sample size in cluster randomisation. BMJ 316 (1998) 549
6. Brun-Buisson C., Legrand P., Rauss A., Richard C., Montravers F., Besbes M., et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110 (1989) 873-881
7. Sun X., Wagner D.P., and Knaus W.A. Does selective decontamination of the digestive tract reduce mortality for severely ill patients?. Crit Care Med 24 (1996) 753-755
8. Krueger W.A., Lenhart F.P., Neeser G., Ruckdeschel G., Schreckhase H., Eissner H.J., et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166 (2002) 1029-1037
9. De Jonge E. Effects of selective decontamination of digestive tract on mortality and antibiotic resistance in the intensive-care unit. Curr Opin Crit Care 11 (2005) 144-149
10. Silvestri L., Van Saene H.K., Milanese M., Gregori D., and Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect 65 (2007) 187-203
11. De Jonge E., Schultz M.J., Spanjaard L., Bossuyt P.M., Vroom M.B., Dankert J., et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362 (2003) 1011-1016
12. Hammond J.M., Potgieter P.D., Saunders G.L., and Forder A.A. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340 (1992) 5-9
13. Verwaest C., Verhaegen J., Ferdinande P., Schetz M., Van den B.G., Verbist L., et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 25 (1997) 63-71
14. Salyers A.A., Moon K., and Schlesinger D. The human intestinal tract - a hotbed of resistance gene transfer? Part I. Clinical Microbiology Newsletter 29 (2007) 17-22
15. Van Saene H.K., Taylor N., Damjanovic V., and Sarginson R.E. Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr Drug Targets 9 (2008) 419-421
16. Hammond J.M., and Potgieter P.D. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 23 (1995) 637-645
17. Cerda E., Abella A., De la Cal M.A., Lorente J.A., Garcia-Hierro P., Van Saene H.K., et al. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study. Ann Surg 245 (2007) 397-407
18. De la Cal M.A., Cerda E., Van Saene H.K., Garcia-Hierro P., Negro E., Parra M.L., et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56 (2004) 175-183
19. Silvestri L., Van Saene H.K., Milanese M., Fontana F., Gregori D., Oblach L., et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 23 (2004) 921-926
20. Viviani M., Van Saene H.K., Dezzoni R., Silvestri L., Di L.R., Berlot G., et al. Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose-response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 33 (2005) 361-372